We are hosting an in-person panel discussion with some incredible Physicians from Valley Health to discuss the topic of 'Living with MBC While Raising Children' on Saturday, June 8th! Admission is free for anyone interested in attending. @robertalom3

Another terrific episode, full of wisdom! Great job Stephanie Walker on this episode. Listen wherever you get your podcasts or on our website at ourmbclife.org #cancer #metastatic #Equity #RuralCancer

You are loved. Pass it on.

Home from hospital after a talc pleurodesis. Mostly successful, w/ some insurance for my lower lobe, which is a bit scarred from the past few years. That was a process! 🥴But kudos to The Christ Hospital Health Network for an overall great experience. On the mend w/ an awesome breakfast.

Looking forward to reading this one!

'It's not about rebranding yourself, it's about stepping into your truth' yes!

Immediate follow Dr Eric Roeland, MD, FAAHPM, FASCO (& many thanks!)
'It's easy for an oncologist to stand at a podium and say that an exciting new drug was ‘well-tolerated,’ but I can tell you that people experiencing even low-grade symptoms over time would not agree,” Roeland said

'I want the minimum treatment for maximum benefit.' ~Manju George MVSc PhD Rectal Cancer Survivor, when asked for her response to data presented by speakers on overtreatment, need for biomarkers to predict treatment response, and trial design that help us find these answers. #AACR24

Excited for this session & curious... who is currently working on AI-directed / supported pathology? I'd love to chat. Trying to help support usage & feel like the more I know, the better I can advocate. AI sometimes gets a bad wrap & we need to communicate value clearly! #AACR24

Comparison of CDK 4/6 inhibitor adverse events - a thorough review and excellent comparison of the the three, including risk factors- Table 1 & 2 summaries 💙 Needed and OPEN ACCESS! Thank you to the authors Demi Wekking, Matteo Lambertini, MD PhD et al. #MBC #bcsm pubmed.ncbi.nlm.nih.gov/38245458/

#AACR attendees: if you hear anything of interest to the gyn cancer community please post with the #gyncsm hashtag. Thanks AACR

Yes!!

And there will be additional experts in the audience for this session. Patient / research advocates effectively translate & communicate science EVERY SINGLE DAY to their communities. When we are on your grants/projects/studies, we can help! #AACR24 AACR #AACR2024 AdvocateCollaborative (ACE)

#TDxD now U.S. FDA approved for pan-tumor w/ HER2 IHC3+ solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options.

Based on DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02:

- Dose 5.4 mg/kg
- Common AE: fatigue,…

An impactful topic during our MBC Conference was 'But You Don't Look Sick' Patient Advocates, Marlena Murphy & Julia Maues, gave us insight to the importance of empathy + not making assumptions about the health status of those living with MBC @robertalom3 app.socialpilot.co/site/video/8ko…

Unfortunately cancer doesn’t care how old you are ❤️‍🩹

Y'all…this was such a fantastic, open, and organic discussion for #AYACancerAwarenessWeek . For the 1st time ever, I openly talk abt the racism & lack of tailored AYA spaces for Black & POC. It's a doozy!

Take a listen 🎧 👉🏽 oncdata.com/news/aya-cance…

Join us 4/5 12-1 p.m. for an engaging and educational webinar on #clinicaltrials for patients with #MBC , part of the EMBRACE #MetastaticBreastCancer Virtual Forum Series.

A panel discussion about finding a clinical trial will follow the presentation.

ms.spr.ly/6015cQYdl

Patients should be the ones to say if their treatment is 'WELL TOLERATED' & discussions about dose reductions need to be part of #sharedDecisionMaking .
❤️ this patient-centered survey & the discussion raised about the tradeoffs in #MBC #BreastCancer #BCSM
ascopubs.org/doi/pdf/10.120…

'We call into❓the practice of repeatedly tx Metastatic #BreastCancer pts w the highest possible dosage (Maximum Tolerated Dose) that causes the most challenging side effects, esp since #MBC pts will repeatedly endure the most toxic dose at the beginning of each new regimen.​'